Trugolf (TRUG) Stock
Small healthcare SPAC waiting to complete a merger. Here's the price, business snapshot, and what's worth knowing about Trugolf in October 2026.
Deep Medicine Acquisition Corp (TRUG) is a special purpose acquisition company (SPAC) formed to identify and merge with a target business, with an apparent focus on healthcare and life sciences opportunities. With a market capitalisation of roughly $2.52M, it is a small, speculative vehicle whose performance depends primarily on whether management completes a business combination and the prospects of any merger target. Investors should note SPACs typically have limited operating history, possible dilution from warrants or additional financing, and liquidity can be low—all factors that can cause wide share-price swings. Regulatory, sector and execution risks matter: a proposed deal may not complete, and valuation changes post-merger can be substantial. This summary is general, educational information only and not personalised investment advice. Consider your own risk tolerance and consult a regulated adviser before investing; returns are not guaranteed and values can fall as well as rise.
Trugolf (TRUG) Stock Forecast
Analyst price target, next 12 months
$60.00
+6332.2% vs today's $0.93
Price range over the last 12 months
Close to its 12-month low
Analysts covering Trugolf have a consensus 12-month target of $60.00, above the current price of $0.93.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 25 May 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying TruGolf's stock with a target price of $60, indicating significant growth potential.
Financial Health
TruGolf is performing well with strong revenue, cash flow, and profit margins.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
SPAC mechanics explained
SPACs raise cash to find a target and can fast-track listings, though outcomes vary and deals may not complete — consider this execution risk.
Healthcare focus
A target in life sciences could offer growth exposure, but regulatory approval paths and clinical risks can strongly affect valuation.
Small-cap dynamics
With a low market cap and likely limited liquidity, shares may move sharply on news; suitable only for investors who accept higher volatility.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
